1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Coloplast AS

Kristian Villumsen

Holtedam 1 3, Humlebaek 3050
Phone: 4549111111


Coloplast A/S PT Raised to DKK835 at Barclays
Nov 22, 2022 07:52am
Berenberg Reiterates Buy Rating on Coloplast A/S
Nov 17, 2022 08:52am
Coloplast: Recession-Resilient But Still A Bit Too Expensive
Nov 09, 2022 13:11pm

Coloplast''s full-year revenue grew and EPS declined slightly. See why the stock is still a bit overvalued and not a good investment currently.

Source:Seeking Alpha
Coloplast A/S (CLPBF) Q4 2022 Earnings Call Transcript
Nov 07, 2022 16:28pm

Coloplast A/S (OTCPK:CLPBF) Q4 2022 Earnings Conference Call November 07, 2022 09:00 AM ET Company Participants Kristian Villumsen - President & Chief Executive Officer Anders…

Source:Seeking Alpha
Coloplast ASB GAAP EPS of $22.11, revenue of $6.05B beats by $3.04B (OTCMKTS:CLPBF)
Nov 07, 2022 15:30pm

Coloplast ASB press release (CLPBF): Q4 GAAP EPS of $22.11.Revenue of $6.05B (+20.8% Y/Y) beats by $3.04B.

Source:Seeking Alpha
Coloplast A/S 2022 Q4 - Results - Earnings Call Presentation (OTCMKTS:CLPBF)
Nov 07, 2022 14:41pm

The following slide deck was published by Coloplast A/S in conjunction with their 2022 Q4 earnings call.

Source:Seeking Alpha
Coloplast launches Saffron Fixation System for Prolapse Repair
Oct 06, 2022 14:00pm

Coloplast is introducing the Saffron Fixation System designed for ease and reliability during pelvic floor reconstruction for women who suffer from pelvic organ prolapse (POP). “Our goal was to create an easy-to-use fixation tool that enables physicians to consistently attach sutures to the ligaments of the pelvic floor. We want to invest in products that help surgeons treat women suffering